Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0N3ZN
|
|||
| Former ID |
DIB012250
|
|||
| Drug Name |
MEDI-8662
|
|||
| Synonyms |
Q/LAIV-BFS; Quadrivalent influenza vaccine (intranasal), MedImmune; Influenza virus vaccine (quadrivalent, intranasal), MedImmune; Live-attenuated influenza virus vaccine (quadrivalent, intranasal), MedImmune
Click to Show/Hide
|
|||
| Indication | Influenza virus infection [ICD-11: 1E30-1E32] | Phase 3 | [1] | |
| Company |
Medlmmune LLC
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00952705) A Study to Evaluate the Immunogenicity of Quadrivalent LAIV (MEDI8662) in Adults 18 to 49 Years of Age. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.